1. Home
  2. BLIN vs CELU Comparison

BLIN vs CELU Comparison

Compare BLIN & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridgeline Digital Inc.

BLIN

Bridgeline Digital Inc.

HOLD

Current Price

$1.18

Market Cap

14.6M

Sector

Technology

ML Signal

HOLD

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$0.80

Market Cap

17.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLIN
CELU
Founded
2000
2016
Country
United States
United States
Employees
N/A
115
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.6M
17.3M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
BLIN
CELU
Price
$1.18
$0.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$4.62
$6.00
AVG Volume (30 Days)
146.4K
129.8K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,568,000.00
N/A
Revenue This Year
$22.67
N/A
Revenue Next Year
$21.08
$76.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.69
$0.56
52 Week High
$1.74
$4.35

Technical Indicators

Market Signals
Indicator
BLIN
CELU
Relative Strength Index (RSI) 53.57 51.76
Support Level $0.86 $0.69
Resistance Level $1.30 $0.86
Average True Range (ATR) 0.09 0.07
MACD -0.01 0.02
Stochastic Oscillator 35.16 70.19

Price Performance

Historical Comparison
BLIN
CELU

About BLIN Bridgeline Digital Inc.

Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.

About CELU Celularity Inc.

Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.

Share on Social Networks: